• August 7, 2020

Tuberous Sclerosis Alliance Lauds FDA Approval of Epidiolex® to Treat Seizures in People with Tuberous Sclerosis Complex - Odessa American: Wire News

e-Edition Subscribe

Tuberous Sclerosis Alliance Lauds FDA Approval of Epidiolex® to Treat Seizures in People with Tuberous Sclerosis Complex

Print
Font Size:
Default font size
Larger font size

Posted: Friday, July 31, 2020 8:43 pm | Updated: 9:03 pm, Fri Jul 31, 2020.

SILVER SPRING, Md., July 31, 2020 /PRNewswire/ -- Today, the Tuberous Sclerosis Alliance (TS Alliance) lauds the U.S. Food and Drug Administration's (FDA's) approval of Epidiolex® oral solution to treat seizures in people one year of age and older who have tuberous sclerosis complex (TSC). Affecting approximately 50,000 in the United States and 1 million worldwide, TSC is a genetic disorder that causes non-cancerous tumors to form in vital organs; it's also the leading genetic cause of both epilepsy and autism.

"Up to 85 percent of those affected by TSC experience seizures at some point in their lifetime," explained TS Alliance President & CEO Kari Luther Rosbeck. "Unfortunately, existing medications don't always effectively control them. Our organization and the TSC community certainly welcome a new option such as Epidiolex, which is the second FDA-approved drug specific to TSC."

Manufactured by GW Pharmaceuticals and distributed in the United States by Greenwich Biosciences, Epidiolex is a plant-derived cannabinoid prescription medicine and the only current FDA-approved form of cannabidiol (CBD). In 2018, the FDA approved the drug to treat people two years of age and older with Lennox-Gastaut syndrome (LGS) or Dravet syndrome.

"We are grateful for the dogged commitment of GW Pharmaceuticals and especially for the TSC clinical trial volunteers, researchers and clinicians who made this possible," said TS Alliance Chief Scientific Officer Steven L. Roberds, PhD. "Epidiolex provides a standardized formulation of CBD with evidence of effectiveness supported by rigorous, well-controlled clinical trials."

Established in 1974, the Tuberous Sclerosis Alliance is an internationally recognized nonprofit organization dedicated to finding a cure for tuberous sclerosis complex while improving the lives of those affected. The organization accomplishes this by developing programs, support services and resource information; stimulating and sponsoring research; and creating and implementing public and professional education programs designed to heighten awareness of the disease. For more information, visit tsalliance.org or email info@tsalliance.org.

Contact: Jaye Isham VP, Communications Strategy Tuberous Sclerosis Alliance 301.562.9890 jisham@tsalliance.org

View original content to download multimedia: http://www.prnewswire.com/news-releases/tuberous-sclerosis-alliance-lauds-fda-approval-of-epidiolex-to-treat-seizures-in-people-with-tuberous-sclerosis-complex-301104240.html

SOURCE Tuberous Sclerosis Alliance

© 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Odessa, TX

Current Conditions

Sunny
91°
Humidity: 26%
Winds: SSE at 15mph
Feels Like: 91°

Your Extended Forecast

Tomorrow

weather
High 100°/Low 74°
Mostly clear. Lows overnight in the mid 70s.

saturday

weather
High 99°/Low 73°
Sunshine. Highs in the upper 90s and lows in the low 70s.

sunday

weather
High 99°/Low 73°
Sunshine. Highs in the upper 90s and lows in the low 70s.
Online Features

Pet Central

pets

Having a pet is a lot of responsibility, and we’ll help by giving you lots of tips and tricks! More >>

Fitness

Fitness

Our fitness articles will help teach you how to work out with gym- and home-based exercises. More >>

Crosswords

Crosswords

Enjoy the crosswords challenge in our free daily puzzles, from the harder Sunday crossword to the quicker daily. More >>

Sudoku

Sudoku

Every Sudoku has a unique solution that can be reached logically. Enter numbers into the blank spaces so that each row, column and 3x3 box contains the numbers 1 to 9. More >>




  • ALL-ACCESS: Subscribe to our e-edition and premium website at myoaoa.com.
    You can read your daily newspaper without taking a walk to the driveway.
    Look back at yesterday's newspaper, or issues from months ago with our archive feature.
    Call circulation at 432-337-7314 to sign up today.